We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Iovance Biotherapeutics Inc. misled investors about factors affecting revenue for two cancer therapies in advance of a recent financial report that caused a 45% stock drop, investors say in a pair of ...

The company also develops DCVax-Direct, that has completed Phase I clinical trials to treat inoperable solid tumors, as well as a range of types of cancers. Northwest Biotherapeutics, Inc. was ...